RMOC shared care guidance: draft shared care protocols, consultation 6

Nancy Kane, Senior Medical Information Scientist, Regional Drug & Therapeutics CentrePublished

Following publication of the RMOC Shared Care for Medicines Guidance – a Standard Approach, the following draft shared care protocols have been developed by the RMOC Shared Care Working Group and are now opened for national consultation. They documents are intended to represent the minimum information required to support safe, effective sharing of prescribing of the specified drugs. The shared care protocols have been drafted in line with the agreed RMOC process using key sources such as the BNF, relevant Summaries of Product Characteristics, MHRA safety warnings, national guidance and specialist input.

The four drafts included in this consultation are:

  • Leflunomide
  • Mercaptopurine
  • Hydroxycarbamide
  • Information on shared care medicines for patients and carers

This is consultation 6 in this work stream; other consultations can be viewed at the links above. A list of future topics is available in the RMOC shared care work plan. Please note that due to the proposed schedule consultations may overlap and run in parallel.

The consultation will run for six weeks, and closes at 5pm on Thursday 9th December 

All comments are welcomed and will be considered and utilised to shape the final draft SCPs prior to their publication. General comments made during earlier consultations do not need to be submitted again, but will be carried forward as appropriate.

Please use the template provided to make all comments. Comments should be sent to rmoc.north@nhs.net by the deadline above.

Attachments